Additionally, previous reports showed that GSK-3β inhibitors potentiated the antitumor effect of gemcitabine and cisplatin; in addition, chloroquine potentiated the antitumor effect of GSK-3β inhibitors in BC cells [10]. This evidence concerns the gene GSK3B and breast cancer.